Biomerica (BMRA) Assets Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -15.93% |
| Nov 30, 2025 | -15.24% |
| Aug 31, 2025 | -14.72% |
| May 31, 2025 | -19.45% |
| Feb 28, 2025 | -25.11% |
| Nov 30, 2024 | -21.10% |
| Aug 31, 2024 | -11.92% |
| May 31, 2024 | -7.83% |
| Feb 29, 2024 | -8.15% |
| Nov 30, 2023 | -6.51% |
| Aug 31, 2023 | -5.96% |
| May 31, 2023 | -5.74% |
| Feb 28, 2023 | -0.02% |
| Nov 30, 2022 | 12.07% |
| Aug 31, 2022 | 18.01% |
| May 31, 2022 | 29.43% |
| Feb 28, 2022 | 51.32% |
| Nov 30, 2021 | 39.73% |
| Aug 31, 2021 | 33.17% |
| May 31, 2021 | 31.29% |
| Aug 31, 2020 | 47.89% |
| May 31, 2020 | 50.95% |
| Feb 29, 2020 | 14.47% |
| Nov 30, 2019 | 8.01% |
| Aug 31, 2019 | 6.22% |
| May 31, 2019 | -2.88% |
| Feb 28, 2019 | -4.81% |
| Nov 30, 2018 | -2.97% |
| Aug 31, 2018 | -7.07% |
| May 31, 2018 | -5.17% |
| Aug 31, 2017 | -6.69% |
| May 31, 2017 | -8.12% |
| Feb 28, 2017 | -4.41% |
| Nov 30, 2016 | -1.40% |
| Aug 31, 2016 | -3.31% |
| May 31, 2016 | -3.61% |
| Feb 29, 2016 | -1.30% |
| Nov 30, 2015 | -0.64% |
| Aug 31, 2015 | 0.52% |
| May 31, 2015 | 3.21% |
| Feb 28, 2015 | 1.70% |
| Nov 30, 2014 | 5.32% |
| Aug 31, 2014 | 6.75% |
| May 31, 2014 | 9.30% |